Benefits from Treatment and Control of Patients with Resistant Hypertension

<table>Survival rates in patients with malignant hypertension at various stages (Group 1–4) treated either medically or surgically (modified from Smithwick and Thompson [<a href="/journals/ijhy/2011/318549/#B39">39</a>]).</table>

International Journal of Hypertension

fig2

Figure 2

Figure 2: Benefits from Treatment and Control of Patients with Resistant Hypertension 